RM
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
36.862
Exchange
XNYS - New York Stock Exchange, Inc
2.9
Last period Current ratio
24%
Current ratio has increased in 5 years
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Resmed
Company Analysis
RMD valuation, rating, competitors, insights and company profile
Eyestock Rating
RMD financial analysis by Eyestock methodology
Valuation
RMD valuation using historical relative method
Statements
RMD Income Statements, Balance Sheet and Cash Flow Statements
Dividends
RMD dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
Resmed`s Current ratio for the last twelve months ended 2024-06-30 is 2.9
